Drugs News and Research

RSS

REGENHU announces its participation in the FLAMIN-GO project aimed at developing "personalized" treatments against rheumatoid arthritis

REGENHU announced its participation in the FLAMIN-GO research project aimed at developing an organ-on-chip technology for clinical trials on Rheumatoid Arthritis.

From regenHU Ltd. 4 Feb 2021

Study: Nalfurafine drug can help treat spinal morphine-induced itch in pregnant women

For years, many pregnant women and surgery patients have suffered from chronic itching when they get spinal or epidural morphine to reduce pain.

4 Feb 2021

Oncotarget publishes new research on geroscience

Dr. Mikhail V. Blagosklonny, M.D., Ph.D., Editor-in-Chief of Oncotarget, and Professor, at Roswell Park Cancer Institute, published "The goal of geroscience is life extension" which was selected as the Featured Cover Paper for Volume 12 Issue 3 and reported that although numerous drugs seemingly extend healthspan in mice, only a few extend lifespan in mice and only one does it consistently.

4 Feb 2021

Researchers define key questions to help the UK government for next biosecurity threat

During the summer of 2019, a global team of experts put their heads together to define the key questions facing the UK government when it comes to biological security.

4 Feb 2021

NeuroVision Imaging receives ADDF funding to develop biomarker tests for Alzheimer's disease

NeuroVision Imaging Inc., announced today it has received an investment from the Alzheimer's Drug Discovery Foundation to support developing reliable, affordable biomarker tests for Alzheimer's disease and other forms of dementia and neurodegenerative disorders.

3 Feb 2021

Rescheduling drugs can reduce use as well as the dangers, study finds

Many nations place drugs into various schedules or categories according to their risk of being abused and their medical value.

3 Feb 2021

New drug cocktail offers hope to patients with highly drug-resistant tuberculosis

A new three-drug, all-oral, six-month treatment is providing hope to patients in Tajikistan with highly drug-resistant forms of tuberculosis, which until now had limited treatment options and poor prognosis.

3 Feb 2021

Study gives new clues to how muscle wasting occurs on a cellular level

Muscle wasting, or the loss of muscle tissue, is a common problem for people with cancer, but the precise mechanisms have long eluded doctors and scientists. Now, a new study led by Penn State researchers gives new clues to how muscle wasting happens on a cellular level.

3 Feb 2021

Research could open the door to next-generation of cancer drugs that work better

Some of the most commonly used drugs for treating hereditary breast and ovarian cancers may not work the way we thought they did, according to new University of Colorado Boulder research.

3 Feb 2021

Moffitt researchers reveal why some ovarian cancer patients evolve better than others

The prognosis of ovarian cancer is poor, with an estimated five-year survival of only 40% for advanced disease, the stage at which most ovarian carcinomas are diagnosed.

3 Feb 2021

CU researchers awarded NEI's 3D ROC prize to accelerate development of new therapies

Natalia Vergara, PhD, assistant professor of ophthalmology at the University of Colorado School of Medicine, has been awarded a 3D ROC prize by the National Eye Institute for her research team's work to create better models to accelerate the development of new therapies for retinal diseases.

3 Feb 2021

Scalp cooling physically protects hair follicles from chemotherapy drugs, research shows

Ground-breaking research from the University of Huddersfield, announced ahead of World Cancer Day 2021, proves that scalp cooling physically protects hair follicles from chemotherapy drugs.

3 Feb 2021

Tiny molecular motions are of key significance in modern anti-cancer drugs

Modern immunotherapeutic anti-cancer drugs support a natural mechanism of the immune system to inhibit the growth of cancer cells.

3 Feb 2021

Novel 3D-printed esophageal stents could revolutionize the delivery of cancer treatment

World-first 3D printed esophageal stents developed by the University of South Australia could revolutionize the delivery of chemotherapy drugs to provide more accurate, effective and personalized treatment for patients with esophageal cancer.

3 Feb 2021

Researchers survey repurposed drugs that inhibit SARS-CoV-2 replication in vitro

A new study by researchers at the University of Manchester, UK, reports on the compounds of interest that were identified as having potential for the treatment of COVID-19, from a library of almost 2,000 compounds from the APExBIO DiscoveryProbe library.

3 Feb 2021

Researchers report trial results of rectal microbicides at HIV R4P Virtual Conference

Researchers seeking to develop on-demand and behaviorally congruent HIV prevention options for people who practice anal sex are reporting the results of three early phase clinical trials of rectal microbicides at this week's HIV Research for Prevention (HIV R4P) Virtual Conference.

3 Feb 2021

Study: Brain hormones could improve metabolism and fight obesity

A mitochondrial hormone expressed by cells deep in the brain appears to play a role in improving metabolism and fighting off obesity, according to a new study in mice.

3 Feb 2021

Study could help understand mechanisms of drug molecules to mitigate COVID-19 infection

As the scientific community continues researching the novel coronavirus, experts are developing new drugs and repurposing existing ones in hopes of identifying promising candidates for treating symptoms of COVID-19.

3 Feb 2021

Advances in tumor models could expand effectiveness of cancer immunotherapy

Scientists are hoping advances in cancer research could lead to a day when a patient's own immune system could be used to fight and destroy a wide range of tumors.

3 Feb 2021

New process separates beneficial glucocorticoids from unwanted side-effects

A collaboration led by Scripps Research has developed a way to separate the beneficial anti-inflammatory properties of a group of steroids called glucocorticoids from some of their unwanted side-effects, through an optimization process they named "ligand class analysis."

3 Feb 2021

Drugs News and Research

REGENHU announces its participation in the FLAMIN-GO project aimed at developing "personalized" treatments against rheumatoid arthritis

Study: Nalfurafine drug can help treat spinal morphine-induced itch in pregnant women

Oncotarget publishes new research on geroscience

Researchers define key questions to help the UK government for next biosecurity threat

NeuroVision Imaging receives ADDF funding to develop biomarker tests for Alzheimer's disease

Rescheduling drugs can reduce use as well as the dangers, study finds

New drug cocktail offers hope to patients with highly drug-resistant tuberculosis

Study gives new clues to how muscle wasting occurs on a cellular level

Research could open the door to next-generation of cancer drugs that work better

Moffitt researchers reveal why some ovarian cancer patients evolve better than others

CU researchers awarded NEI's 3D ROC prize to accelerate development of new therapies

Scalp cooling physically protects hair follicles from chemotherapy drugs, research shows

Tiny molecular motions are of key significance in modern anti-cancer drugs

Novel 3D-printed esophageal stents could revolutionize the delivery of cancer treatment

Researchers survey repurposed drugs that inhibit SARS-CoV-2 replication in vitro

Researchers report trial results of rectal microbicides at HIV R4P Virtual Conference

Study: Brain hormones could improve metabolism and fight obesity

Study could help understand mechanisms of drug molecules to mitigate COVID-19 infection

Advances in tumor models could expand effectiveness of cancer immunotherapy

New process separates beneficial glucocorticoids from unwanted side-effects

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News